-
Sichuan promotes the optimization and upgrading of all aspects of "production, purchase, storage and sales" of grain
Time of Update: 2022-09-04
A few days ago, the Sichuan Provincial Development and Reform Commission, the Sichuan Provincial Grain and Material Reserve Bureau and other departments jointly issued the "Sichuan Province Grain and
-
Lycium barbarum aqueous extract inhibits protein aggregation by inducing mitochondrial UPR
Time of Update: 2022-02-21
Using an AD transgenic nematode model, Chang Chen's group from the Institute of Biophysics, Chinese Academy of Sciences found that lycium barbarum extract (LBE) inhibited the development of Alzheimer's disease by activating the antioxidant system and mitochondrial unfolded protein response (mtUPR).
-
Isolation point air disinfection device
Time of Update: 2022-01-22
UV+O2→O-+O* (active oxygen) O+O2→O3 (ozone), it is well known that ozone has a strong oxidizing effect on organic matter, degrading the organic matter in the gas and converting it into low molecular compounds, water and carbon dioxide .
Vacuum sterilization filter performance requirements According to the BS3928:1969 test method, the filtration efficiency exceeds 99.
-
More than 30 mutations of the new coronavirus have appeared in people with AIDS, and the emergency use of the new coronavirus vaccine has been extended to over 3 years of age. The progress of new
Time of Update: 2021-06-28
Research finds that new crown vaccine recipients have lower levels of antibodies against Indian variantsResearch finds that new crown vaccine recipients have lower levels of antibodies against Indian variantsSource: the LancetSource: the Lancet Source: the LancetIn a work published in The Lancet on June 3, the latest laboratory data showed that the blood of the vaccinators can identify and fight against the new SARS-CoV-2 delta variant discovered in India for the first time (B.
-
The third bispecific antibody has been approved by the FDA. Is there an outbreak in the field of dual antibodies
Time of Update: 2021-06-01
Last week, the US FDA accelerated the approval of the bispecific antibody Rybrevant (amivantamab-vmjw) developed by Johnson & Johnson's Janssen Company for the treatment of EGFR exon 20 Patients with non-small cell lung cancer (NSCLC) with insertion mutations.
-
Innovative first-line therapy for gastric cancer is recognized by FDA as breakthrough therapy
Time of Update: 2021-05-02
Today, Amgen announced that the US FDA has granted its research FGFR2b antibody therapy bemarituzumab breakthrough therapy designation, combined with chemotherapy, for the first-line treatment of HER2-negative locally advanced or metastatic gastric cancer and gastroesophageal junction (GEJ ) Cancer patients.
-
China's cardiovascular disease patients reached 330 million, related prevention and control, drug prices are concerned
Time of Update: 2020-11-14
Health China Action (2019-2030) gives specific instructions for the prevention and treatment of cardiovascular diseases, and clearly promotes the "three high" co-management, to carry out overweight obesity, blood pressure and blood sugar increase, blood lipid abnormalities and other high-risk groups of disease risk assessment and intervention guidance, do a good job of hypertension, diabetes, blood lipid abnormal standardized management.
-
Nails, peeling onions, through bamboo poles! Multi-province start the drug collection order gun
Time of Update: 2020-10-25
A local medical insurance bureau related to the person in charge of recruitment has revealed that at present, each province a year to carry out centralized procurement of three batches to four batches or so, each batch of varieties is not necessarily more, the plan through about two years to basically achieve the goal of drug collection.
-
Liu Yankai group, Ocean University of China: asymmetric organic catalytic synthesis of spiro bridge or cage heterocyclic compounds
Time of Update: 2019-09-16
The heterocyclic skeleton containing spiro bridged or cage like multi ring system can be used as an important intermediate for the synthesis of compounds with pharmacological and physiological activit
-
Immunity: new research reveals human defense mechanism and cancer transmission mechanism
Time of Update: 2019-08-15
August 15, 2019 / BIOON / - with the help of new technologies, researchers at the University of Turku in Finland have obtained more detailed information on the diversity of the human lymphatic system
